Drug reference
Prophylaxis and treatment of postoperative pain and inflammation associated with cataract surgery | Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients ▶TO THE EYE ▶Adult: (consult product literature)
PDF page 1246
Avoid sunlight. corneal epithelial breakdown (if evidence of, then discontinue immediately)
PDF page 1246
Scottish Medicines Consortium (SMC) decisions The Scottish Medicines Consortium has advised (May 2017) that nepafenac (Nevanac ®) 3 mg/mL eye drops are accepted for use within NHS Scotland for the reduction in risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
PDF page 1247
→Appendix 1: NSAIDs
PDF page 1247
▶Uncommon Eye discomfort. eye disorders. eye inflammation ▶Rare or very rare Allergic dermatitis. corneal deposits. dizziness. dry eye. headache. nausea ▶Frequency not known Cutis laxa. vision disorders. vomiting
PDF page 1247
There can be variation in the licensing of different medicines containing the same drug. Eye drops EXCIPIENTS: May contain Benzalkonium chloride, disodium edetate ▶Nevanac (Novartis Pharmaceuticals UK Ltd) Nepafenac 1 mg per 1 ml Nevanac 1mg/ml eye drops | 5 ml P £14.92 DT = £14.92 Nepafenac 3 mg per 1 ml Nevanac 3mg/ml eye drops | 3 ml P £14.92 DT = £14.92 CORTICOSTEROIDS eiiii F 709
PDF page 1247
(consult product literature)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1246
